Latest News for: glp-2

Edit

ADIA Takes Direct Stake in GLP with $1.5bn Capital Commitment

The Arabian Post 29 Aug 2025
Global logistics investor GLP will receive up to $1.5 billion from a wholly owned subsidiary of the Abu Dhabi Investment Authority, signalling the sovereign wealth fund’s first move from limited partner to direct stakeholder in the firm.
Edit

New GLP-1 Pill Helps People Lose 23 Pounds in Study

Hibbing Daily Tribune 28 Aug 2025
Key Takeaways ... .
Edit

Switching between brand-name GLP-1s? Follow these 7 tips for a smooth and safe transition

Caledonian Record 28 Aug 2025
GoodRx reports tips for safely switching between GLP-1 medications due to side effects, insurance changes, or treatment goals ....
Edit

\u2018It\u2019s definitely a common thing\u2026\u2019: Why GLP-1 drugs like Ozempic and Wegovy may trigger hair loss and how to minimise it, according to a dermatologist

Indian Express 28 Aug 2025
GLP-1 drugs such as Ozempic, ...
Edit

GLP-1 Drugs Are Good For Climate Change, Heart Study Says

The Greeneville Sun 28 Aug 2025
Key Takeaways ....
Edit

Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 ...

Nasdaq Globe Newswire 28 Aug 2025
Teva Announces FDA Approval and Launch of Generic Saxenda® (liraglutide injection) – First Generic GLP-1 Indicated for Weight Loss ... .
Edit

Baker McKenzie Advises GLP on up to USD 1.5 Billion Investment from Abu Dhabi Investment Authority (Baker & McKenzie LLP)

Public Technologies 28 Aug 2025
) Baker McKenzie acted as international counsel to GLP Pte ... (GLP) in connection with Abu Dhabi Investment Authority (ADIA)'s up to USD 1.5 billion investment in GLP. As detailed in GLP's press release, ...
Edit

GLP-1 Analogues Market Forecast: USD 471.1 Billion by 2032

GetNews 28 Aug 2025
"The market for GLP-1 Analogue class drugs is highly consolidated, with two major players controlling major shares of the market ... North America leads in market share, supported by accessibility and demand for GLP-1 analogues.
Edit

Use of Weight Loss Drugs Rises Nationwide as Serena Williams Shares Her Story

Nashville Pride 28 Aug 2025
I do everything but shortcuts,” she added her voice to the growing list of public figures discussing the use of GLP-1 medications such as Ozempic, Wegovy, and Mounjaro ... adults specifically used GLP-1s for weight loss in 2024.
Edit

Expect health insurance prices to rise next year, brokers and experts say

Maryland Daily Record 28 Aug 2025
. .
Edit

New GLP-1 pill for weight loss may be closer to reality as drugmaker Eli Lilly ...

Lodi News Sentinel 27 Aug 2025
Eli Lilly's GLP-1 pill, orforglipron, shows promising trial results for weight loss and type 2 diabetes. Global regulatory approval is planned for 2025 ....
Edit

Tasso, Inc. and SheMed Provide At-Home Blood Testing to UK Women for Personalized GLP-1 Treatments

The Joplin Globe 27 Aug 2025
SEATTLE & LONDON--(BUSINESS WIRE)--Aug 27, 2025-- ... .
Edit

Weight loss drug debate: Experts urge strict guidelines for GLP-1 drugs

India Today 27 Aug 2025
Weight loss drug debate Experts urge strict guidelines for GLP drugs ... .
Edit

GLP-1s can help address LGBTQ healthcare barriers: experts

Washington Blade 27 Aug 2025
When Piccoli decided to get on a GLP-1, it wasn’t a “short cut” to drop weight – it was a way for her to live her life comfortably ... GLP-1 drugs have caused quite a stir since becoming more integrated into mainstream medicine ... How GLP-1s work.
Edit

Eli Lilly’s Announcement Regarding Oral GLP-1 Orforglipron (Chugai Pharmaceutical Co Ltd)

Public Technologies 27 Aug 2025
Eli Lilly's Announcement Regarding Oral GLP-1 Orforglipron. In ATTAIN-2, orforglipron met the primary and all key secondary endpoints, with compelling efficacy results and a safety profile consistent with injectable GLP-1 medicines.

Article Search

tools
×
×
×
×